[Digoxin plasma levels in four different prescription schedules of common use in clinical practice].
BACKGROUND
The different therapeutic schedules used for the prescription of digoxin have little theoretical support.


OBJECTIVE
To measure digoxin plasma levels in patients using four different prescription schedules.


METHODS
Four groups of patients were studied. Group I corresponded to 56 patients taking digoxin 0.25 mg/day, from Monday to Friday. Group II corresponded to 30 patients taking digoxin 0.25 mg/day, from Monday to Saturday. Group III corresponded to 53 patients taking digoxin 0.25 mg/day continuously. Group IV corresponded to 36 patients taking digoxin 0.125 mg/day continuously. Plasma digoxin levels were measured in two consecutive Mondays before taking the daily dose of the drug. Serum creatinine was also measured and creatinine clearance was calculated. The therapeutic plasma concentration range was set between 0.5 and 2 ng/ml.


RESULTS
Mean plasma digoxin levels were 1.15 +/- 0.8 ng/ml in group I, 1.4 +/- 0.55 ng/ml in group II, 1.68 +/- 0.7 ng/ml in group III and 1.14 +/- 0.43 ng/ml in group IV. 93% of patients in group I, 80% of patients in group II, 75% of patients in group III and 94% of patients in group IV had therapeutic digoxin levels. A low creatinine clearance, an age over 65 and interactions with other drugs were risk factors associated with supratherapeutic levels, mostly seen in group II and group III with 20% and 24% respectively.


CONCLUSIONS
Most patients using digoxin with different therapeutic schedules had plasma drug levels within the therapeutic range.
Reinbach
Rolando
R
Facultad de Medicina, Universidad de Concepción, Unidad Académica Hospital Las Higueras de Talcahuano. rreinbach@hotmail.com
Villa
Lorenzo
L
Giraudo
Paolo
P
Venegas
Reinaldo
R
Fernández
Pola
P
D000368:Aged; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000097:blood*; D003404:Creatinine / Q000097:blood; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D002316:Cardiotonic Agents; D004077:Digoxin; D003404:Creatinine